Fundz

Repligen Corp reported raising $48 Million in an initial SEC Form D filing, from an offering of $48 Million

PUBLIC · RGENJun 13, 2019

Amount Raised

$48 Million

$48 Million sold, per SEC Form D (first sale Jun 13, 2019)

Round Type

Venture

WalthamManufacturingBiotechnologyHealthcareBiopharma

Quick answer

Repligen Corporation raised $48 Million in a funding round, dated June 13, 2019. Repligen Corporation is based in Waltham, Massachusetts, United States.

How much did Repligen Corporation raise?
Repligen Corporation raised $48 Million in a funding round on June 13, 2019.
What does Repligen Corporation do?
Repligen Corporation (NASDAQ: RGEN) is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing..
Where is Repligen Corporation based and how big is it?
Repligen Corporation is based in Waltham, Massachusetts, United States. Fundz records about 1,305 employees.
Who are the decision-makers at Repligen Corporation?
Fundz holds 2 contacts at Repligen Corporation, including the Senior TA Sourcing Partner. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biopharma around the same time

Companies in the same sectors as Repligen Corporation that raised within 45 days of this round, from Fundz verified event records.

Who to call at Repligen Corporation, and when

A new round usually means Repligen Corporation is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Repligen Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Repligen Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Repligen Corporation. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Repligen Corporation

Location

41 Seyon Street

Waltham, Massachusetts, United States

About

Repligen Corporation (NASDAQ: RGEN) is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the company see our website at www.repligen.com, and follow us on LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Repligen Corporation raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsOlivia, Senior TA Sourcing Partner hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Repligen Corporation's next move

See what Strategic adds

Repligen Corporation raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.